Y.B Urban Renewal - Residential Development LTD Logo

Y.B Urban Renewal - Residential Development LTD

A company focused on urban renewal projects and residential development initiatives.

CSURE-M | TA

Overview

Corporate Details

ISIN(s):
IL0001110134
LEI:
Country:
Israel
Address:
2 Hahadarim Street, 7712102 Ashdod

Description

Y.B Urban Renewal - Residential Development LTD is a company focused on urban renewal projects. Formerly known as Cannassure Therapeutics Ltd, the company has transitioned from the medical cannabis sector. Its current mission is to facilitate the economic, cultural, and environmental renewal of inner-city areas through residential development initiatives.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-15 19:43
Trading in the company's shares (ISIN IL0001110134) will be renewed on Monday, …
Hebrew (modern) 113.5 KB
2025-05-05 15:53
The securities not included in the Illiquid list as of May 4th 2025 due to mar…
Hebrew (modern) 217.1 KB
2025-05-05 11:32
Suspension of trading due to failure in publication of financial reports s for …
Hebrew (modern) 79.7 KB
2025-04-28 18:40
Securities that have joined the program and the Market Makers that will operate…
Hebrew (modern) 366.8 KB
2025-04-20 18:21
Failure in publishing financial reports-Notification
Hebrew (modern) 128.0 KB
2025-03-06 18:39
Illiquid Candidates securities list as of May 4th 2025
Hebrew (modern) 245.6 KB
2024-07-28 18:05
The company's securities will be transferred from the maintenance list to the m…
Hebrew (modern) 106.5 KB
2024-07-11 17:14
Changes in the company's share symbol correction: YBRD-M
Hebrew (modern) 104.0 KB
2024-07-09 17:01
Changes in the company's name and security, effective as of July 11, 2024
Hebrew (modern) 105.9 KB
2024-06-25 19:48
Changes in Sector Classification of Listed Companies as of Sunday, June 30, 2024
Hebrew (modern) 135.9 KB
2024-03-21 18:45
Will trade on Monday March 25 2024, with unlimited price fluctuation at the ope…
Hebrew (modern) 137.2 KB
2023-07-13 20:43
Transfer to the Maintenance List on July 17, 2023
Hebrew (modern) 149.7 KB
2023-07-03 19:48
Companies that do not comply with the Maintenance Rules and are candidates to b…
Hebrew (modern) 116.3 KB
2023-01-15 17:37
Non-Compliance with the Maintenance Rules Based on Data as of December 31, 2022…
Hebrew (modern) 132.9 KB
2021-01-07 15:45
On Sunday, 10 January 2021, trading will commence in the following Security: CA…
Hebrew (modern) 186.1 KB

Automate Your Workflow. Get a real-time feed of all Y.B Urban Renewal - Residential Development LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Y.B Urban Renewal - Residential Development LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Y.B Urban Renewal - Residential Development LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aldeyra Therapeutics, Inc. Logo
Develops medications for immune-mediated ocular and systemic diseases.
United States of America
ALDX
Alector, Inc. Logo
Clinical-stage biotech using immuno-neurology to treat neurodegenerative diseases.
United States of America
ALEC
ALK-Abelló Logo
A pharmaceutical company specializing in allergy prevention, diagnosis, and treatment.
Denmark
ALK
Alkaloid AD Logo
Manufactures generic pharmaceuticals, cosmetics, and chemical products.
North Macedonia
ALK
Alkermes plc. Logo
Develops and commercializes medicines for central nervous system (CNS) diseases.
United States of America
ALKS
Allarity Therapeutics, Inc. Logo
A clinical-stage biopharma using diagnostics to develop targeted cancer therapies.
United States of America
ALLR
ALLERGY THERAPEUTICS PLC Logo
Immunology company developing aluminum-free vaccines and therapies for allergies.
United Kingdom
AGY
Alligator Bioscience Logo
Clinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
Sweden
ATORX
Allogene Therapeutics, Inc. Logo
Develops off-the-shelf allogeneic CAR T therapies for cancer and autoimmune diseases.
United States of America
ALLO
Almirall S.A. Logo
Global biopharmaceutical company specializing in medical dermatology and skin health.
Spain
ALM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.